1
|
Elmamoun M, Eraso M, Anderson M, Maharaj A, Coates L, Chandran V, Abogamal A, Adebajo AO, Ajibade A, Ayanlowo O, Azevedo V, Bautista-Molano W, Carneiro S, Goldenstein-Schainberg C, Hernandez-Velasco F, Ima-Edomwonyi U, Lima A, Medina-Rosas J, Mody GM, Narang T, Ortega-Loayza AG, Ranza R, Sharma A, Toloza S, Vega-Espinoza L, Vega-Hinojosa O. International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings. Clin Rheumatol 2020; 39:1839-1850. [PMID: 31950441 PMCID: PMC7237392 DOI: 10.1007/s10067-020-04934-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Revised: 12/26/2019] [Accepted: 01/06/2020] [Indexed: 01/17/2023]
Abstract
Background Psoriatic arthritis (PsA) is a challenging heterogeneous disease. The European League Against Rheumatism (EULAR) and the Group for Research and Assessment of Psoriasis and PsA (GRAPPA) last published their respective recommendations for the management of PsA in 2015. However, these guidelines are primarily based on studies conducted in resource replete countries and may not be applicable in countries in the Americas (except Canada and USA) and Africa. We sought to adapt the existing recommendations for these regions under the auspices of the International League of Associations for Rheumatology (ILAR). Process The ADAPTE Collaboration (2009) process for guideline adaptation was followed to adapt the EULAR and GRAPPA PsA treatment recommendations for the Americas and Africa. The process was conducted in three recommended phases: set-up phase; adaptation phase (defining health questions, assessing source recommendations, drafting report), and finalization phase (external review, aftercare planning, and final production). Result ILAR recommendations have been derived principally by adapting the GRAPPA recommendations, additionally, EULAR recommendations where appropriate and supplemented by expert opinion and literature from these regions. A paucity of data relevant to resource-poor settings was found in PsA management literature. Conclusion The ILAR Treatment Recommendations for PsA intends to serve as reference for the management of PsA in the Americas and Africa. This paper illustrates the experience of an international working group in adapting existing recommendations to a resource-poor setting. It highlights the need to conduct research on the management of PsA in these regions as data are currently lacking.Key Points • The paper presents adapted recommendations for the management of psoriatic arthritis in resource-poor settings. • The ADAPTE process was used to adapt existing GRAPPA and EULAR recommendations by collaboration with practicing clinicians from the Americas and Africa. • The evidence from resource-poor settings to answer clinically relevant questions was scant or non-existent; hence, a research agenda is proposed. |
Electronic supplementary material The online version of this article (10.1007/s10067-020-04934-7) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- M Elmamoun
- Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Canada
| | - M Eraso
- Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Canada
| | - M Anderson
- Library and Information Services, University Health Network, Toronto, Canada
| | - A Maharaj
- Prince Mshiyeni Memorial Hospital, Durban, South Africa
| | - L Coates
- University of Oxford, Oxford, UK
| | - Vinod Chandran
- Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Canada. .,Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Canada. .,Institute of Medical Science, University of Toronto, Toronto, Canada. .,Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. .,Department of Medicine, Memorial University, St. John's, Canada.
| | | | - A Abogamal
- Al-Azhar Faculty of Medicine Cairo, Nasr City, Egypt
| | - A O Adebajo
- University of Sheffield UK, Western Bank, Sheffield, S10 2TN, UK
| | - A Ajibade
- Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun state, Nigeria
| | - O Ayanlowo
- College of Medicine, University of Lagos/Lagos University Teaching Hospital Nigeria, Ishaga Rd, Idi-Araba, Lagos, Nigeria
| | - V Azevedo
- Federal University of Parana, Curitiba, PR, Brazil
| | - W Bautista-Molano
- University Hospital Fundación Santa Fe de Bogotá and School of Medicine Universidad Militar Nueva Granada, Bogota, Colombia
| | - S Carneiro
- State University of Rio de Janeiro and Federal University of Rio de Janeiro, Av. Pedro Calmon, 550 - Cidade Universitária da Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-901, Brazil
| | - C Goldenstein-Schainberg
- Disciplina de Reumatologia, LIM-17, Hospital das Clinicas HCFMUSP, Faculty of Medicine - University of Sao Paulo, Sao Paulo, SP, Brazil
| | | | - U Ima-Edomwonyi
- College of Medicine, University of Lagos/Lagos University Teaching Hospital Nigeria, Ishaga Rd, Idi-Araba, Lagos, Nigeria
| | - A Lima
- Regional University of Blumenau (FURB), Blumenau, SC, Brazil
| | - J Medina-Rosas
- Posthumous, University of Valle, University of La Sabana, Imbanaco Medical Center, Cali, Colombia
| | - G M Mody
- University of KwaZulu-Natal, Durban, South Africa
| | - T Narang
- Post Graduate Institute of Medical Education & Research, Chandigarh, 160012, India
| | - A G Ortega-Loayza
- Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, USA
| | - R Ranza
- Rheumatology Unit, Federal University of Uberlandia, Uberlândia, MG, Brazil
| | - A Sharma
- Post Graduate Institute of Medical Education & Research, Chandigarh, 160012, India
| | - S Toloza
- Ministry of Health, Catamarca, Catamarca, Argentina
| | | | | |
Collapse
|